Platelet-activating factor receptor antagonist attenuates endotoxin-induced vascular hyporeactivity in the pithed rat

By Yoshikawa D.   Shiga T.   Saito S.   Morita T.   Imai T.   Goto F.  

European Journal of Pharmacology, Vol. 342, Iss. 2, 1998-01 ,pp. : 241-245

Elsevier

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Characterization of the physicochemical properties of the micelles by the novel platelet activating factor receptor antagonist E5880

By Asai Y.   Watanabe S.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 49, Iss. 3, 2000-05 ,pp. : 219-223

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of SY0916, a platelet-activating factor receptor antagonist, on the angiogenesis of human umbilical vascular endothelial cells

By Wu Lian-Qiu   OuYang Xue-Yu   Liu Yang   Peng Shan-Ying   Wang Lin   Wang Wen-Jie  

Journal of Asian Natural Products Research, Vol. 13, Iss. 11, 2011-10 ,pp. : 984-992

Taylor & Francis Ltd

Access to resources Recommend Favorite

Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite